Our findings enrich the mechanistic knowledge of how ALYREF regulates ovarian cancer progression via m5C, which may have significant application for new therapeutic strategies for ovarian cancer and other cancers (Fig. 8H). This evidence concerns the gene ALYREF and ovarian carcinoma.